We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-3 of 3 results
  1. Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy

    Purpose

    Osteonecrosis of the jaw (ONJ) presents a severe side-effect of intravenous bisphosphonate (i.v. BP) treatment; yet, the pathoethiological...

    Tatjana I. Jung, Falk Hoffmann, ... Dieter Felsenberg in Journal of Cancer Research and Clinical Oncology
    Article 22 August 2009
  2. Osteonecrosis of the jaw

    Bisphosphonates are effective therapy for osteoporosis, Paget’s disease, and metastatic bone disease. Generally, the side effects of bisphosphonates...

    Philip N. Sambrook, Peter Ebeling in Current Rheumatology Reports
    Article 01 April 2008
  3. Fat body mass, leptin and femur bone mineral density in hip-fractured women

    Fat body mass (FBM) is a strong predictor of both bone mineral density (BMD) and risk of hip fracture, but the mechanisms responsible are not...

    M. Di Monaco, F. Vallero, ... A. Cavanna in Journal of Endocrinological Investigation
    Article 01 December 2003
Did you find what you were looking for? Share feedback.